962 related articles for article (PubMed ID: 23382293)
1. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
[TBL] [Abstract][Full Text] [Related]
2. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
[TBL] [Abstract][Full Text] [Related]
3. Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease.
Idilman IS; Keskin O; Elhan AH; Idilman R; Karcaaltincaba M
Scand J Gastroenterol; 2014 May; 49(5):617-24. PubMed ID: 24694249
[TBL] [Abstract][Full Text] [Related]
4. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy.
van Werven JR; Marsman HA; Nederveen AJ; Smits NJ; ten Kate FJ; van Gulik TM; Stoker J
Radiology; 2010 Jul; 256(1):159-68. PubMed ID: 20574093
[TBL] [Abstract][Full Text] [Related]
5. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
[TBL] [Abstract][Full Text] [Related]
6. MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis.
Runge JH; Smits LP; Verheij J; Depla A; Kuiken SD; Baak BC; Nederveen AJ; Beuers U; Stoker J
Radiology; 2018 Feb; 286(2):547-556. PubMed ID: 28915103
[TBL] [Abstract][Full Text] [Related]
7. Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease.
Idilman IS; Tuzun A; Savas B; Elhan AH; Celik A; Idilman R; Karcaaltincaba M
Abdom Imaging; 2015 Aug; 40(6):1512-9. PubMed ID: 25715922
[TBL] [Abstract][Full Text] [Related]
8. Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy.
Hwang I; Lee JM; Lee KB; Yoon JH; Kiefer B; Han JK; Choi BI
Radiology; 2014 Jun; 271(3):730-8. PubMed ID: 24533869
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.
Tang A; Tan J; Sun M; Hamilton G; Bydder M; Wolfson T; Gamst AC; Middleton M; Brunt EM; Loomba R; Lavine JE; Schwimmer JB; Sirlin CB
Radiology; 2013 May; 267(2):422-31. PubMed ID: 23382291
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive differentiation of simple steatosis and steatohepatitis by using gadoxetic acid-enhanced MR imaging in patients with nonalcoholic fatty liver disease: a proof-of-concept study.
Bastati N; Feier D; Wibmer A; Traussnigg S; Balassy C; Tamandl D; Einspieler H; Wrba F; Trauner M; Herold C; Ba-Ssalamah A
Radiology; 2014 Jun; 271(3):739-47. PubMed ID: 24576046
[TBL] [Abstract][Full Text] [Related]
11. Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging--correlation with histopathologic findings.
Kim SH; Lee JM; Han JK; Lee JY; Lee KH; Han CJ; Jo JY; Yi NJ; Suh KS; Shin KS; Jo SY; Choi BI
Radiology; 2006 Jul; 240(1):116-29. PubMed ID: 16684918
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities.
Guaraldi G; Besutti G; Stentarelli C; Zona S; Nocetti L; Loria P; Ballestri S; Losi L; Torricelli P; Ligabue G
Antivir Ther; 2012; 17(6):965-71. PubMed ID: 22766513
[TBL] [Abstract][Full Text] [Related]
13. Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers.
Bannas P; Kramer H; Hernando D; Agni R; Cunningham AM; Mandal R; Motosugi U; Sharma SD; Munoz del Rio A; Fernandez L; Reeder SB
Hepatology; 2015 Nov; 62(5):1444-55. PubMed ID: 26224591
[TBL] [Abstract][Full Text] [Related]
14. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy.
Guiu B; Petit JM; Loffroy R; Ben Salem D; Aho S; Masson D; Hillon P; Krause D; Cercueil JP
Radiology; 2009 Jan; 250(1):95-102. PubMed ID: 19092092
[TBL] [Abstract][Full Text] [Related]
15. Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy.
Levenson H; Greensite F; Hoefs J; Friloux L; Applegate G; Silva E; Kanel G; Buxton R
AJR Am J Roentgenol; 1991 Feb; 156(2):307-12. PubMed ID: 1898804
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease.
Tang A; Desai A; Hamilton G; Wolfson T; Gamst A; Lam J; Clark L; Hooker J; Chavez T; Ang BD; Middleton MS; Peterson M; Loomba R; Sirlin CB
Radiology; 2015 Feb; 274(2):416-25. PubMed ID: 25247408
[TBL] [Abstract][Full Text] [Related]
17. Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI.
França M; Alberich-Bayarri Á; Martí-Bonmatí L; Oliveira P; Costa FE; Porto G; Vizcaíno JR; Gonzalez JS; Ribeiro E; Oliveira J; Pessegueiro Miranda H
Abdom Radiol (NY); 2017 May; 42(5):1434-1443. PubMed ID: 28110367
[TBL] [Abstract][Full Text] [Related]
18. Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results.
Kühn JP; Hernando D; Muñoz del Rio A; Evert M; Kannengiesser S; Völzke H; Mensel B; Puls R; Hosten N; Reeder SB
Radiology; 2012 Oct; 265(1):133-42. PubMed ID: 22923718
[TBL] [Abstract][Full Text] [Related]
19. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques.
Schwenzer NF; Machann J; Martirosian P; Stefan N; Schraml C; Fritsche A; Claussen CD; Schick F
Invest Radiol; 2008 May; 43(5):330-7. PubMed ID: 18424954
[TBL] [Abstract][Full Text] [Related]
20. Comparison of magnetic resonance spectroscopy, proton density fat fraction and histological analysis in the quantification of liver steatosis in children and adolescents.
Di Martino M; Pacifico L; Bezzi M; Di Miscio R; Sacconi B; Chiesa C; Catalano C
World J Gastroenterol; 2016 Oct; 22(39):8812-8819. PubMed ID: 27818597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
